The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis

Table 1

Prevalence of antihepatitis D virus and hepatitis D virus RNA in HBsAg-positive populations in North Africa.

Year	Category	Tested (n)	Anti-HDV		HDV RNA
			n (%)	95% CI	n (%)	95% CI
Egypt
2000	Out-patients	45	4 (9)	2.91-14.89	1(25)	19-34
2010	Liver disease patients	14	2 (14)	8.94-19.66	-	-
2010	Liver disease patients	30	4 (13)	8.52-18.08	1(25)	17-32
2013	Blood donors	170	8 (5)	1.58-7.82	-	-
2016	Hospital patients	121	10 (8)	2.16-14.44	3(30)	7-74
Libya
2015	General population	346	2(2)	1.0-2.0	-	-
2012	Hospital patients	162	4 (3)	1.0-4.11	1(25)	5-68
Tunisia
2013	General population	464	21(4.5)	1.56-7.44
2013	Liver disease patients	22	6(27.2)	9.87-44.53	2(33)	31-79
2013	Liver disease patients	55	10(18.1)	7.91-28.29	3(30)	29-71
2015	General population	1615	216(2)	1.21- 2.79	-	-
Sudan
2015	Hospital patients	90	4(4.4)	1.75-7.05	-	-
2015	Hemodialysis patients	90	6(7.36)	3.86-10.86	-	-
2015	Pregnant women	90	3(3.3)	1.41-5.19	1(30)	32-69
Mauretania
2008	Blood donors	447	78(19)	15-24	54(69)	52-78
2009	Pregnant women	109	14(13)	8-27	11(79)	42-91
2009	Hospital patients	162	29(18)	14-28	21(72)	51-86
Algeria
2013	General population	296	12(4.0)	2.0-6.0	-	-
Morocco
2010	General population	561	19 (3.0)	1.0-6.0	-	-